WallStreetZenWallStreetZen

NASDAQ: CAMP
Camp4 Therapeutics Corp Stock Ownership - Who owns Camp4 Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Camp4 Therapeutics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kelly GoldCFO2026-08-3110,000$3.96
$39.60kBuy
Andrew J. SchwabDirector2026-08-27400,000$4.04
$1.62MSell
Andrew J. SchwabDirector2026-08-2410$4.50
$45.00Sell
Andrew J. SchwabDirector2026-08-2132,018$4.50
$144.08kSell
Andrew J. SchwabDirector2026-08-20114,700$4.54
$520.74kSell
Daniel TardiffCSci2026-08-191,738$4.76
$8.27kSell
Andrew J. SchwabDirector2026-08-1945,147$4.76
$214.90kSell
Richard A. YoungDirector2026-08-0316,378$1.65
$27.02kBuy
Josh MandelbrehmCEO2026-08-036,551$1.65
$10.81kBuy
Yuri MaricichMed2026-08-036,551$1.65
$10.81kBuy

1 of 2

CAMP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CAMP insiders and whales buy or sell their stock.

CAMP Shareholders

What type of owners hold Camp4 Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Andrew J. Schwab21.95%13,771,452$58.53MInsider
5am Partners VI LLC9.35%5,869,091$24.94MInsider
Enavate Sciences GP LLC6.03%3,785,802$16.09MInsider
Northpond Ventures II GP LLC3.57%2,238,244$9.51MInsider
Ah Equity Partners Bio I LLC3.39%2,125,339$9.03MInsider
Polaris Partners GP X LLC1.45%909,090$3.86MInsider
Amir Nashat1.45%909,090$3.86MInsider
Polaris Management Co VII LLC1.45%909,090$3.86MInsider
Josh Mandelbrehm0.45%284,968$1.21MInsider
Richard A. Young0.30%186,388$792.15kInsider

1 of 3

CAMP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CAMP0.07%49.92%Net SellingNet Selling
PYXS0.04%40.13%Net BuyingNet Buying
ALXO0.08%10.66%Net BuyingNet Selling
TRDA0.06%99.94%Net SellingNet Selling
AKBA0.04%8.06%Net SellingNet Buying
View Top Biotech Stocks

Camp4 Therapeutics Stock Ownership FAQ

Who owns Camp4 Therapeutics?

Camp4 Therapeutics (NASDAQ: CAMP) is owned by 0.07% institutional shareholders, 49.92% Camp4 Therapeutics insiders, and 50.01% retail investors. Andrew J. Schwab is the largest individual Camp4 Therapeutics shareholder, owning 13.77M shares representing 21.95% of the company. Andrew J. Schwab's Camp4 Therapeutics shares are currently valued at $58.53M.

If you're new to stock investing, here's how to buy Camp4 Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.